Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-22-018718

Chief Commercial Officer acquired 805 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Grow Brian Chief Commercial Officer 2022-08-20 Option exercise +805 $1.46 $1,175 87,744 D
Derivatives
Grow Brian Chief Commercial Officer 2022-08-20 Option exercise · Stock Option (Right to Buy) −805 0 D
Loading xslF345X03/form4.xml…